Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis

[1]  Y. Natkunam,et al.  The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation , 2010, Haematologica.

[2]  D. Jukic.  High Numbers of Tumor-Infiltrating Programmed Cell Death 1–Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma , 2010 .

[3]  S. Tangye,et al.  Early commitment of naïve human CD4+ T cells to the T follicular helper (TFH) cell lineage is induced by IL‐12 , 2009, Immunology and cell biology.

[4]  M. Hansmann,et al.  STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line , 2009, Leukemia.

[5]  A. Ray,et al.  STAT6 Activation Confers upon T Helper Cells Resistance to Suppression by Regulatory T Cells1 , 2009, The Journal of Immunology.

[6]  Irah L. King,et al.  T follicular helper cells differentiate from Th2 cells in response to helminth antigens , 2009, The Journal of experimental medicine.

[7]  Irah L. King,et al.  IL-4–producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells , 2009, The Journal of experimental medicine.

[8]  T. Lawrence,et al.  Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. , 2009, Blood.

[9]  K. Tarte,et al.  Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase. , 2009, Cancer research.

[10]  N. Fazilleau,et al.  Follicular helper T cells: lineage and location. , 2009, Immunity.

[11]  A. López-Guillermo,et al.  High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Locksley,et al.  Cytokine-secreting follicular T cells shape the antibody repertoire , 2009, Nature Immunology.

[13]  C. Copie-Bergman,et al.  The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages , 2009, Leukemia.

[14]  Daphne de Jong,et al.  Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols , 2009, Haematologica.

[15]  E. Jaffe,et al.  IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. , 2008, Blood.

[16]  D. Hwang,et al.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. , 2008, Immunity.

[17]  K. Tarte,et al.  CD40 Ligand Protects from TRAIL-Induced Apoptosis in Follicular Lymphomas through NF-κB Activation and Up-Regulation of c-FLIP and Bcl-xL1 , 2008, The Journal of Immunology.

[18]  A. Yoshimura,et al.  STAT6 Inhibits TGF-β1-mediated Foxp3 Induction through Direct Binding to the Foxp3 Promoter, Which Is Reverted by Retinoic Acid Receptor* , 2008, Journal of Biological Chemistry.

[19]  J. Radford,et al.  Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. , 2008, Blood.

[20]  M. Karjalainen‐Lindsberg,et al.  Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. , 2008, Blood.

[21]  C. Mackay,et al.  T follicular helper (TFH) cells in normal and dysregulated immune responses. , 2008, Annual review of immunology.

[22]  G. Salles,et al.  High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  I. Lossos,et al.  HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration. , 2007, Blood.

[24]  P. Khatri,et al.  A systems biology approach for pathway level analysis. , 2007, Genome research.

[25]  Christian Gisselbrecht,et al.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. , 2007, Blood.

[26]  J. Kutok,et al.  Lymphomas can develop from B cells chronically helped by idiotype-specific T cells , 2007, The Journal of experimental medicine.

[27]  Philip M Kluin,et al.  Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  K. Tarte,et al.  Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. , 2007, Blood.

[29]  Jan Delabie,et al.  Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms , 2007, British journal of haematology.

[30]  R. Bende,et al.  Molecular pathways in follicular lymphoma , 2007, Leukemia.

[31]  Marylène Lejeune,et al.  Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  M. Calaminici,et al.  Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Emili Montserrat,et al.  High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. , 2006, Blood.

[34]  B. Nadel,et al.  Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis , 2006, The Journal of experimental medicine.

[35]  Sampsa Hautaniemi,et al.  Differential gene expression in non‐malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP , 2006, British journal of haematology.

[36]  H. Rahn,et al.  Follicular B helper T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression , 2006, European journal of immunology.

[37]  Peter Boyle,et al.  Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. , 2006, Blood.

[38]  A. Anichini,et al.  Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines. , 2006, Blood.

[39]  Karey Shumansky,et al.  Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). , 2005, Blood.

[40]  Ash A. Alizadeh,et al.  Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. , 2005, Blood.

[41]  Peter Joosten,et al.  Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. , 2005, Blood.

[42]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[43]  J. Cyster,et al.  Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5 , 2004, Nature Immunology.

[44]  Karen Leroy,et al.  Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. , 2004, Blood.

[45]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[46]  P. Casali,et al.  Selective Inhibition of Class Switching to IgG and IgE by Recruitment of the HoxC4 and Oct-1 Homeodomain Proteins and Ku70/Ku86 to Newly Identified ATTT cis-Elements* , 2003, Journal of Biological Chemistry.

[47]  M. White,et al.  Interleukin-4-mediated Protection of Primary B Cells from Apoptosis through Stat6-dependent Up-regulation of Bcl-xL* , 2002, The Journal of Biological Chemistry.

[48]  R. Gascoyne,et al.  Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. , 2002, Blood.

[49]  Donna Neuberg,et al.  Center B Cells Using Cdna Arrays Gene Expression Profiling of Follicular Lymphoma and Normal Germinal , 2002 .

[50]  G. Salles,et al.  Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas , 2000, Cancer Immunology, Immunotherapy.

[51]  R. Stahel,et al.  T‐cell derived cytokines co‐stimulate proliferation of CD40‐activated germinal centre as well as follicular lymphoma cells , 1997, Hematological oncology.

[52]  B. Coiffier,et al.  ELEVATED CIRCULATING LEVELS OF TNFα AND ITS p55 SOLUBLE RECEPTOR ARE ASSOCIATED WITH AN ADVERSE PROGNOSIS IN LYMPHOMA PATIENTS , 1996, British journal of haematology.

[53]  P. Rácz,et al.  Differences in the germinal centres of palatine tonsils and lymph nodes. , 1996, Scandinavian journal of immunology.

[54]  P. Gaulard,et al.  Interleukin-2 and interferon-gamma production in follicular lymphomas. , 1991, American journal of clinical pathology.